These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 19036920)

  • 1. Identification of a receptor required for the anti-inflammatory activity of IVIG.
    Anthony RM; Wermeling F; Karlsson MC; Ravetch JV
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19571-8. PubMed ID: 19036920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.
    Yu X; Vasiljevic S; Mitchell DA; Crispin M; Scanlan CN
    J Mol Biol; 2013 Apr; 425(8):1253-8. PubMed ID: 23416198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells.
    Bayry J; Bansal K; Kazatchkine MD; Kaveri SV
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):E24; author reply E25. PubMed ID: 19237553
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.
    Anthony RM; Ravetch JV
    J Clin Immunol; 2010 May; 30 Suppl 1():S9-14. PubMed ID: 20480216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.
    Anthony RM; Kobayashi T; Wermeling F; Ravetch JV
    Nature; 2011 Jun; 475(7354):110-3. PubMed ID: 21685887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
    Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
    Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.
    Campbell IK; Miescher S; Branch DR; Mott PJ; Lazarus AH; Han D; Maraskovsky E; Zuercher AW; Neschadim A; Leontyev D; McKenzie BS; Käsermann F
    J Immunol; 2014 Jun; 192(11):5031-8. PubMed ID: 24760152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for selective recognition of endogenous and microbial polysaccharides by macrophage receptor SIGN-R1.
    Silva-Martín N; Bartual SG; Ramírez-Aportela E; Chacón P; Park CG; Hermoso JA
    Structure; 2014 Nov; 22(11):1595-606. PubMed ID: 25450767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General mechanism for modulating immunoglobulin effector function.
    Sondermann P; Pincetic A; Maamary J; Lammens K; Ravetch JV
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9868-72. PubMed ID: 23697368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
    Schwab I; Biburger M; Krönke G; Schett G; Nimmerjahn F
    Eur J Immunol; 2012 Apr; 42(4):826-30. PubMed ID: 22278120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation.
    Käsermann F; Boerema DJ; Rüegsegger M; Hofmann A; Wymann S; Zuercher AW; Miescher S
    PLoS One; 2012; 7(6):e37243. PubMed ID: 22675478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.
    Requena M; Bouhlal H; Nasreddine N; Saidi H; Gody JC; Aubry S; Grésenguet G; Kazatchkine MD; Sekaly RP; Bélec L; Hocini H
    Immunology; 2008 Apr; 123(4):508-18. PubMed ID: 17999675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo.
    Geijtenbeek TB; Groot PC; Nolte MA; van Vliet SJ; Gangaram-Panday ST; van Duijnhoven GC; Kraal G; van Oosterhout AJ; van Kooyk Y
    Blood; 2002 Oct; 100(8):2908-16. PubMed ID: 12351402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal zone SIGN-R1
    Pirgova G; Chauveau A; MacLean AJ; Cyster JG; Arnon TI
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12295-12305. PubMed ID: 32424104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization and preliminary X-ray diffraction studies of the carbohydrate-recognition domain of SIGN-R1, a receptor for microbial polysaccharides and sialylated antibody on splenic marginal zone macrophages.
    Silva-Martin N; Schauer JD; Park CG; Hermoso JA
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Dec; 65(Pt 12):1264-6. PubMed ID: 20054124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
    Schwab I; Nimmerjahn F
    Nat Rev Immunol; 2013 Mar; 13(3):176-89. PubMed ID: 23411799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran.
    Kang YS; Yamazaki S; Iyoda T; Pack M; Bruening SA; Kim JY; Takahara K; Inaba K; Steinman RM; Park CG
    Int Immunol; 2003 Feb; 15(2):177-86. PubMed ID: 12578847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human DC-SIGN and CD23 do not interact with human IgG.
    Temming AR; Dekkers G; van de Bovenkamp FS; Plomp HR; Bentlage AEH; Szittner Z; Derksen NIL; Wuhrer M; Rispens T; Vidarsson G
    Sci Rep; 2019 Jul; 9(1):9995. PubMed ID: 31292524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
    Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation.
    Brückner C; Lehmann C; Dudziak D; Nimmerjahn F
    Int Immunol; 2017 Dec; 29(11):499-509. PubMed ID: 29300958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.